Paramount Medical Research and Consulting | Middleburg Heights, OH

Research site

(Unclaimed)

Location

18660 Bagley Road Phase II, Middleburg Heights, Ohio, United States of America

Site insights

Top conditions

Top treatments

Upadacitinib

Lutikizumab

Cenerimod

Tofacitinib

Afimetoran

VIB7734

Ibuprofen

Naproxen

Apremilast

BMS-986165

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 19 total trials

A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease (RILIEF)

This is a Phase 3, parallel group, 2-arm, randomized, double blind, placebo-controlled, 52-week treatment study to assess the efficacy and safety of...

Enrolling

Immunoglobulin G4 Related Disease

Drug: Rilzabrutinib

Drug: Placebo

A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

The purpose of this study is to evaluate the effectiveness, safety and tolerability of Afimetoran in participants with active Systemic Lupus Erythema...

Active, not recruiting

Systemic Lupus Erythematosus

Other: Placebo

Drug: Afimetoran

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will evaluate th...

Enrolling

Rheumatoid Arthritis

Drug: Lutikizumab

Drug: Placebo

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

This study is open to adults with systemic lupus erythematosus (SLE). The purpose of this study is to find out whether a medicine called BI 3000202 h...

Begins enrollment in 1 month

Systemic Lupus Erythematosus

Drug: Placebo

Drug: BI 3000202

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus (SELECT-SLE)

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how s...

Enrolling

Systemic Lupus Erythematosus

Drug: Upadacitinib

Drug: Placebo

Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis

Psoriatic arthritis (PsA) is a type of arthritis that happens when the body's immune system attacks healthy cells and tissues causing joint pain, sti...

Enrolling

Psoriatic Arthritis

Drug: Risankizumab

Drug: Lutikizumab

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH)

Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will assess how...

Active, not recruiting

Rheumatoid Arthritis

Drug: Adalimumab

Drug: Upadacitinib